Estrogens and androgens in skeletal physiology and pathophysiology

M Almeida, MR Laurent, V Dubois… - Physiological …, 2017 - journals.physiology.org
Estrogens and androgens influence the growth and maintenance of the mammalian
skeleton and are responsible for its sexual dimorphism. Estrogen deficiency at menopause …

Adverse effects of androgen deprivation therapy and strategies to mitigate them

PL Nguyen, SMH Alibhai, S Basaria, AV D'Amico… - European urology, 2015 - Elsevier
Context Androgen-deprivation therapy (ADT) is a key component of treatment for aggressive
and advanced prostate cancer, but it has also been associated with adverse effects on bone …

EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer

P Cornford, J Bellmunt, M Bolla, E Briers, M De Santis… - European urology, 2017 - Elsevier
Objective To present a summary of the 2016 version of the European Association of Urology
(EAU)–European Society for Radiotherapy & Oncology (ESTRO)–International Society of …

Sex steroid actions in male bone

D Vanderschueren, MR Laurent, F Claessens… - Endocrine …, 2014 - academic.oup.com
Sex steroids are chief regulators of gender differences in the skeleton, and male gender is
one of the strongest protective factors against osteoporotic fractures. This advantage in bone …

Structural basis for antagonism and resistance of bicalutamide in prostate cancer

CE Bohl, W Gao, DD Miller, CE Bell… - Proceedings of the …, 2005 - National Acad Sciences
Carcinoma of the prostate is the most commonly diagnosed cancer in men. The current
pharmacological treatment of choice for progressive androgen-dependent prostate cancer is …

Contemporary role of androgen deprivation therapy for prostate cancer

V Pagliarulo, S Bracarda, MA Eisenberger, N Mottet… - European urology, 2012 - Elsevier
CONTEXT: Androgen deprivation therapy (ADT) for prostate cancer (PCa) represents one of
the most effective systemic palliative treatments known for solid tumors. Although clinical …

Medication-induced osteoporosis: screening and treatment strategies

K Panday, A Gona… - Therapeutic advances in …, 2014 - journals.sagepub.com
Drug-induced osteoporosis is a significant health problem and many physicians are
unaware that many commonly prescribed medications contribute to significant bone loss …

Aging and the male reproductive system

JM Kaufman, B Lapauw, A Mahmoud… - Endocrine …, 2019 - academic.oup.com
This narrative review presents an overview of current knowledge on fertility and reproductive
hormone changes in aging men, the factors driving and modulating these changes, their …

Drug-induced osteoporosis: mechanisms and clinical implications

G Mazziotti, E Canalis, A Giustina - The American journal of medicine, 2010 - Elsevier
Drug-induced osteoporosis is common and has a significant impact on the prognosis of
patients suffering from chronic debilitating diseases. Glucocorticoids are the drugs causing …

Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine …

P Chang, KM Szymanski, RL Dunn… - The Journal of …, 2011 - auajournals.org
Purpose: Measuring the health related quality of life of patients with prostate cancer in
routine clinical practice is hindered by the lack of instruments enabling efficient, real-time …